With 34% Ownership, Sight Sciences, Inc. (NASDAQ:SGHT) Has Piqued the Interest of Institutional Investors
Yahoo FinanceApr 22 10:47 ET
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
MENLO PARK, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative,
GlobeNewswireApr 18 16:05 ET
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure With OMNI Surgical System Technology Is Effective
InvestingApr 10 16:18 ET
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)
TipRanksApr 10 05:40 ET
Express News | Needham Reiterates Hold on Sight Sciences
Moomoo 24/7Apr 10 05:24 ET
Sight Sciences(SGHT.US) Officer Sells US$24,851.55 in Common Stock
$Sight Sciences(SGHT.US)$ Officer HAYDEN JEREMY B. sold 4,893 shares of Common Stock on Apr 3, 2024 at an average price of $5.079 for a total value of $24,851.55.Source: Announcement What is statement
moomoo NewsApr 4 20:10 ET
Sight Sciences(SGHT.US) Officer Sells US$17,339.71 in Common Stock
$Sight Sciences(SGHT.US)$ Officer Park Sam Boong sold 3,414 shares of Common Stock on Apr 3, 2024 at an average price of $5.079 for a total value of $17,339.71.Source: Announcement What is statement o
moomoo NewsApr 4 20:05 ET
Sight Sciences(SGHT.US) Officer Sells US$15,887.11 in Common Stock
$Sight Sciences(SGHT.US)$ Officer Badawi David sold 3,128 shares of Common Stock on Apr 3, 2024 at an average price of $5.079 for a total value of $15,887.11.Source: Announcement What is statement of
moomoo NewsApr 4 20:05 ET
Sight Sciences(SGHT.US) Officer Sells US$63,848.11 in Common Stock
$Sight Sciences(SGHT.US)$ Officer Badawi Paul sold 12,571 shares of Common Stock on Apr 3, 2024 at an average price of $5.079 for a total value of $63,848.11.Source: Announcement What is statement of
moomoo NewsApr 4 20:05 ET
Sight Sciences(SGHT.US) Officer Sells US$51,414.72 in Common Stock
$Sight Sciences(SGHT.US)$ Officer Bauerlein Alison sold 10,123 shares of Common Stock on Apr 3, 2024 at an average price of $5.079 for a total value of $51,414.72.Source: Announcement What is statemen
moomoo NewsApr 4 20:00 ET
Sector Update: Health Care Stocks Flat Pre-Bell Wednesday
Health care stocks were flat pre-bell Wednesday, with both the Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) unchanged. Vanda Pharmaceuticals' (VNDA) shares rose 25
MT NewswiresApr 3 08:58 ET
Express News | Sight Sciences Shares Are Trading Higher After the Company Announced Data From Studies of Two of Its Glaucoma and Dry Eye Technologies Will Be Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Moomoo 24/7Apr 3 07:26 ET
Update: Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Extend Gains to Premarket
(Updates with the stock move in the headline and the last paragraph.) Sight Sciences (SGHT) said late Tuesday that results from studies of two of its glaucoma and dry eye technologies will be presente
MT NewswiresApr 3 05:25 ET
Sight Sciences (SGHT) Shares Soar Amidst Industry Event Buzz
Sight Sciences, Inc. (NASDAQ: SGHT) observed a notable surge in its stock value during the after-hour session on Tuesday, marking an increase of 18.20% to $6.43. This rise followed a preceding uptick of 2.45% during the regular trading session, culminating in a closing price of $5.44. The upward momentum of SGHT stock on the US ...
Stocks TelegraphApr 3 04:12 ET
Sight Sciences Shares Rise 17% Ahead of Data Presentations
By Ben Glickman Shares of Sight Sciences rose late Tuesday after the company said it would present data from two studies of its systems. The stock was up 17% to $6.36 in after-hours trading, followi
WSJApr 2 18:56 ET
Sight Sciences to Present Data From Studies of Glaucoma, Dry Eye Technologies -- Shares Jump After Hours
Sight Sciences (SGHT) said late Tuesday that results from studies of two of its glaucoma and dry eye technologies will be presented at this year's meeting of the American Society of Cataract and Refra
MT NewswiresApr 2 17:14 ET
CALM,PLAY and VNDA Are Among After Hour Movers
Seeking AlphaApr 2 16:43 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday's after-market session. The market value of their outstanding shares is at $44.8 million. Aesthetic Medical Intl (N
BenzingaApr 2 16:31 ET
Press Release: Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annua
Dow JonesApr 2 16:05 ET
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
Globe NewswireMar 26 16:05 ET
No Data
No Data